Favipiravir is an antiviral drug that selectively inhibits RNA-dependent RNA polymerase.
It is primarily used in the treatment of influenza and has been investigated for SARS-CoV-2.
The presence of a fluorine atom contributes to its pharmacokinetics and activity profile.